Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02713828
Title Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PrECOG, LLC.

lung non-small cell carcinoma


Glembatumumab vedotin

Age Groups: adult
Covered Countries USA

No variant requirements are available.